Mechanism of Hepatic Parenchyma-Specific Contrast of Microbubble-Based Contrast Agent for Ultrasonography: Microscopic Studies in Rat Liver
暂无分享,去创建一个
[1] Francesco Conversano,et al. Experimental Investigations of Nonlinearities and Destruction Mechanisms of an Experimental Phospholipid-Based Ultrasound Contrast Agent , 2007, Investigative radiology.
[2] Jonathan R Lindner,et al. Effect of Microbubble Ligation to Cells on Ultrasound Signal Enhancement: Implications for Targeted Imaging , 2006, Investigative radiology.
[3] Z. Fayad,et al. Clearance of Iron Oxide Particles in Rat Liver: Effect of Hydrated Particle Size and Coating Material on Liver Metabolism , 2006, Investigative radiology.
[4] A. Tanimoto,et al. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. , 2006, European journal of radiology.
[5] H. Turoğlu,et al. Colloid scintigraphy in non-alcoholic steatohepatitis: A conventional diagnostic method for an emerging disease , 2006, Nuclear medicine communications.
[6] Alexander L. Klibanov,et al. Microbubble Contrast Agents: Targeted Ultrasound Imaging and Ultrasound-Assisted Drug-Delivery Applications , 2006, Investigative radiology.
[7] M. Kudo,et al. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images , 2005, Journal of Gastroenterology.
[8] M. Sasamata,et al. Real-time blood-pool images of contrast enhanced ultrasound with Definity in the detection of tumour nodules in the liver. , 2005, The British journal of radiology.
[9] R. Watanabe,et al. Characterization of tumor imaging with microbubble-based ultrasound contrast agent, sonazoid, in rabbit liver. , 2005, Biological & pharmaceutical bulletin.
[10] Emilio Quaia,et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. , 2004, Radiology.
[11] P. Burns,et al. Blood flow patterns in focal liver lesions at microbubble-enhanced US. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.
[12] S. Kumano,et al. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions. , 2003, AJR. American journal of roentgenology.
[13] R. Watanabe,et al. Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model. , 2003, Biological & pharmaceutical bulletin.
[14] T. Skotland,et al. Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres , 2003, Cell and Tissue Research.
[15] G. Schmid-Schönbein,et al. Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intravital microscopy study in rats. , 2002, Radiology.
[16] G. Bongartz,et al. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. , 2002, European journal of radiology.
[17] Flemming Forsberg,et al. Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase. , 2002, Radiology.
[18] Steve Paddock,et al. Confocal reflection microscopy: the "other" confocal mode. , 2002, BioTechniques.
[19] D. Cosgrove,et al. Liver lesions: intermittent second-harmonic gray-scale US can increase conspicuity with microbubble contrast material-early experience. , 2000, Radiology.
[20] B. Choi,et al. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. , 2000, Radiology.
[21] T. Murakami,et al. Superparamagnetic iron oxide–enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading , 2000, Hepatology.
[22] P. Burns,et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. , 2000, Radiology.
[23] H. Spiegel,et al. Evaluation of hepatic microcirculation by in vivo microscopy. , 1999, Journal of investigative surgery : the official journal of the Academy of Surgical Research.
[24] L. Hoff,et al. Acoustic properties of NC100100 and their relation with the microbubble size distribution. , 1999, Investigative radiology.
[25] J. Olynyk,et al. Isolation and primary culture of rat Kupffer cells , 1998, Journal of gastroenterology and hepatology.
[26] A. Broillet,et al. Gray-scale liver enhancement in VX2 tumor-bearing rabbits using BR14, a new ultrasonographic contrast agent. , 1997, Investigative radiology.
[27] M. Kage,et al. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver , 1996, Hepatology.
[28] Luc Bouwens,et al. Quantitation, tissue distribution and proliferation kinetics of kupffer cells in normal rat liver , 1986, Hepatology.
[29] D. Knook,et al. Relation between localization and function of rat liver Kupffer cells. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[30] T. Skotland,et al. Disposition of perfluorobutane in rats after intravenous injection of Sonazoid. , 2006, Ultrasound in medicine & biology.
[31] P. Burns,et al. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. , 2000, Investigative radiology.
[32] B. Goldberg,et al. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. , 1999, Radiology.
[33] E. Wisse,et al. Cell biology and kinetics of Kupffer cells in the liver. , 1989, International review of cytology.